Mitochondrial stress response in drug-induced liver injury

被引:13
作者
Zheng, Jing [1 ,3 ]
Yuan, Qiulin [1 ]
Zhou, Cao [1 ]
Huang, Weifeng [1 ,2 ]
Yu, Xiang [1 ]
机构
[1] China Three Gorges Univ, Coll Med, Inst Infect & Inflammat, Dept Microbiol & Immunol, 8 DaXue Rd, Yichang 443002, Hubei, Peoples R China
[2] Yantai Univ, Minist Educ, Sch Pharm, Key Lab Mol Pharmacol & Drug Evaluat, Yantai 264005, Peoples R China
[3] China Three Gorges Univ, Peoples Hosp, Yichang 443000, Peoples R China
关键词
Drug-induced liver injury; Mitochondrial stress response; Mitochondrial homeostasis; Adaptive protective mechanism; AUTOPHAGY; HEPATOTOXICITY; MITOPHAGY; PROTEASE; DYNAMICS; DYSFUNCTION; BIOGENESIS; METABOLISM; DICLOFENAC; METFORMIN;
D O I
10.1007/s11033-021-06674-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drug-induced liver injury (DILI) caused by the ingestion of medications, herbs, chemicals or dietary supplements, is a clinically widespread health problem. The underlying mechanism of DILI is the formation of reactive metabolites, which trigger mitochondrial oxidative stress and the opening of mitochondrial permeability transition (MPT) pores through direct toxicity or immune response, leading to cell inflammation, apoptosis, and necrosis. Traditionally, mitochondria play an indispensable role in maintaining the physiological and biochemical functions of cells by producing ATP and mediating intracellular signal transduction; drugs can typically stimulate the mitochondria and, in the case of sustained stress, can eventually cause impairment of mitochondrial function and metabolic activity. Meanwhile, the mitochondrial stress response, as an adaptive protective mechanism, occurs when mitochondrial homeostasis is threatened. In this review, we summarize the relevant frontier researches of the protective effects of mitochondrial stress response in DILI as well as the potential related mechanisms, thus providing some thoughts for the clinical treatment of DILI.
引用
收藏
页码:6949 / 6958
页数:10
相关论文
共 95 条
[1]   Mitophagy as a stress response in mammalian cells and in respiring S-cerevisiae [J].
Abeliovich, Hagai ;
Dengjel, Joern .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 :541-545
[2]  
Aithal GP., 2019, MEDICINE, V47, P734, DOI DOI 10.1016/J.MPMED.2019.08.005
[3]   Role of p62/SQSTM1 beyond autophagy: a lesson learned from drug-induced toxicity in vitro [J].
Alegre, Fernando ;
Moragrega, Angela B. ;
Polo, Miriam ;
Marti-Rodrigo, Alberto ;
Esplugues, Juan V. ;
Blas-Garcia, Ana ;
Apostolova, Nadezda .
BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (03) :440-455
[4]   Folding the Mitochondrial UPR into the Integrated Stress Response [J].
Anderson, Nadine S. ;
Haynes, Cole M. .
TRENDS IN CELL BIOLOGY, 2020, 30 (06) :428-439
[5]   Mitophagy Is Required for Acute Cardioprotection by Simvastatin [J].
Andres, Allen M. ;
Hernandez, Genaro ;
Lee, Pamela ;
Huang, Chengqun ;
Ratliff, Eric P. ;
Sin, Jon ;
Thornton, Christine A. ;
Damasco, Marichris V. ;
Gottlieb, Roberta A. .
ANTIOXIDANTS & REDOX SIGNALING, 2014, 21 (14) :1960-1973
[6]   Autophagy as a rescue mechanism in Efavirenz-induced mitochondrial dysfunction A lesson from hepatic cells [J].
Apostolova, Nadezda ;
Gomez-Sucerquia, Leysa J. ;
Gortat, Anna ;
Blas-Garcia, Ana ;
Esplugues, Juan V. .
AUTOPHAGY, 2011, 7 (11) :1402-1404
[7]   Modulatory effects of statins on the autophagy: A therapeutic perspective [J].
Ashrafizadeh, Milad ;
Ahmadi, Zahra ;
Farkhondeh, Tahereh ;
Samarghandian, Saeed .
JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (04) :3157-3168
[8]   Simvastatin affects Nrf2/MAPK signaling pathway and hepatic histological structure change in Gambusia affinis [J].
Bao, Shuang ;
Lin, Jiawei ;
Xie, Meinan ;
Wang, Chao ;
Nie, Xiangping .
CHEMOSPHERE, 2021, 269
[9]   Lysosomal Cholesterol Accumulation Sensitizes To Acetaminophen Hepatotoxicity by Impairing Mitophagy [J].
Baulies, Anna ;
Ribas, Vicent ;
Nunez, Susana ;
Torres, Sandra ;
Alarcon-Vila, Cristina ;
Martinez, Laura ;
Suda, Jo ;
Ybanez, Maria D. ;
Kaplowitz, Neil ;
Garcia-Ruiz, Carmen ;
Fernandez-Checa, Jose C. .
SCIENTIFIC REPORTS, 2015, 5
[10]   Hepatotoxicity of statins and other lipid-lowering agents [J].
Bjornsson, Einar S. .
LIVER INTERNATIONAL, 2017, 37 (02) :173-178